 |
|
octreotide pamoate
A synthetic long-acting octapeptide analogue of endogenous somatostatin. Octreotide pamoate binds to somatostatin receptors expressed by some neuroendocrine and non-neuroendocrine tumor cells, thereby initiating somatostatin receptor-mediated apoptosis. Other possible antineoplastic activities of this agent include suppression of tumor angiogenesis and tumor growth-promoting insulin-like growth factor 1 (IGF-1). Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | Octreotide Pamoate LAR(SMS 201-995)
OP LAR
Sandostatin pamoate
Sandostatin pamoate LAR | | | | US brand name: | | OncoLAR | | | | Code names: | | SMS 201-995 pa
SMS 201-995 pa LAR | | |
|
|
